Abstract: A liquid cooling device includes a water cooling radiator, a first pump and a cold plate. The water cooling radiator has a first surface and a second surface, the first surface and the second surface are located on opposite sides of the water cooling radiator, the first pump is disposed on the first surface or the second surface of the water cooling radiator, and the cold plate is disposed on the second surface of the water cooling radiator.

Abstract: The present invention relates to a method of treating or preventing respiratory disease, comprising the administration of an effective amount of the composition to a subject with respiratory disease via inhalation, wherein the composition comprises Houttuynia Cordata Thunb or the extracts of Houttuynia Cordata Thunb in the form of an aerosol and/or a spray.

Abstract: An electrical connector includes a housing, a plurality of terminals and a grounding member. The plurality of terminals are provided in the housing to be arranged side by side in a row. At least a part of the plurality of terminals are multiple ground terminals and multiple signal terminals. Each terminal has a mating segment and a soldering segment. Each mating segment is a cantilever structure relative to the corresponding soldering segment. The grounding member includes multiple mounting portions. The multiple mounting portions are respectively mounted to the soldering segments of the multiple ground terminals.

Abstract: A liquid cooling device includes a water cooling radiator, a first pump and a cold plate. The water cooling radiator has a first surface and a second surface, the first surface and the second surface are located on opposite sides of the water cooling radiator, the first pump is disposed on the first surface or the second surface of the water cooling radiator, and the cold plate is disposed on the second surface of the water cooling radiator.

Abstract: A method for improving the oxygen-releasing ability of hemoglobin, hemoglobin variants, recombinant hemoglobin or hemoglobin-based blood substitutes to organs or peripheral tissues in human bodies is disclosed by administering a compound of phthalides to a subject in need thereof. The compound of phthalides is characterized by a phthalide functional group which is represented as Formula I, and forms at least one hydrogen bond with ?Arg141 of hemoglobin, hemoglobin variants, recombinant hemoglobin or hemoglobin-based blood substitutes, stabilizing the ?1/?2 interface of hemoglobin, further stabilizing the oxygenated hemoglobin, hemoglobin variants, recombinant hemoglobin or hemoglobin-based blood substitutes in the low oxygen affinity “T” state and facilitating the oxygen release to the organs or the peripheral tissues.

Abstract: The present invention relates to a method for substituting for or acting with the hyperbaric oxygen therapy to improve hypoxia, comprising the step of: administrating a phthalide compound to a subject in need thereof, wherein the phthalide compound can increase the oxygen release efficiency of blood hemoglobin (Hb) in the subject and further increase the cellular oxygenation level, and when the phthalide compound substitutes for or act with the hyperbaric oxygen therapy, the common adverse side effects of the hyperbaric oxygen therapy, such as barotrauma, decompression sickness and oxygen poisoning, are prevented. The phthalide compound is used to substitute for or act with 2,3-BPG, to modulate and decrease the oxygen affinity of hemoglobin (Hb), to increase the oxygen release efficiency of hemoglobin (Hb) to tissue cells, thereby achieving a normal cellular oxygenation level and maintaining the cellular oxygenation level in a normal range.

Abstract: The present invention relates to a method for treating Alzheimer's disease and 2,3-BPG metabolic disorder induced morbidities, comprising administrating a phthalide compound to an Alzheimer's disease patient or a patient having 2,3-BPG metabolic disorder induced morbidities, wherein the method is characterized by that the phthalide compound has the same effect as 2,3-BPG on modulating hemoglobin to reduce its oxygen affinity and can thus act as a 2,3-BPG functional substitute when the 2,3-BPG concentration is too low in the Alzheimer's disease patient or in the patient having 2,3-BPG metabolic disorder induced morbidities to maintain the normal oxygen release function of hemoglobin and therefore to maintain the normal cellular oxygenation level.

Abstract: The present invention relates to a method for preventing cancer by using a phthalide compound, wherein the phthalide compound has an effect of increasing the oxygen release efficiency of hemoglobin (Hb) of a subject to increase the oxygenation level of organs and tissue cells, thereby preventing the cellular oxygenation level against falling below the critical cellular oxygen requirements under which the normal cells can turn cancerous. Although cancer may be caused by a variety of reasons, including congenital inheritance, external environment, air pollution or poor living and dietary habits, there is only one primary and common reason in causing cancers, the excessively low cellular oxygenation level. When the oxygenation level of any cell falls below 60% of its physiological oxygen requirements, the normal cell may turn cancerous.

Abstract: The present invention relates to a method for substituting for or acting with the hyperbaric oxygen therapy to improve hypoxia, comprising the step of: administrating a phthalide compound to a subject in need thereof, wherein the phthalide compound can increase the oxygen release efficiency of blood hemoglobin (Hb) in the subject and further increase the cellular oxygenation level, and when the phthalide compound substitutes for or act with the hyperbaric oxygen therapy, the common adverse side effects of the hyperbaric oxygen therapy, such as barotrauma, decompression sickness and oxygen poisoning, are prevented. The phthalide compound is used to substitute for or act with 2,3-BPG, to modulate and decrease the oxygen affinity of hemoglobin (Hb), to increase the oxygen release efficiency of hemoglobin (Hb) to tissue cells, thereby achieving a normal cellular oxygenation level and maintaining the cellular oxygenation level in a normal range.

Abstract: The present invention relates to a method for increasing the oxygen release efficiency of a hemoglobin-based blood substitute by using a phthalide compound, comprising the steps of: administering to a subject in need thereof the phthalide compound or co-administering to the subject in need thereof the phthalide compound along with the hemoglobin-based blood substitute, wherein the phthalide compound has an effect of increasing the oxygen release efficiency of the hemoglobin-based blood substitute, wherein the hemoglobin-based blood substitute can be fetal hemoglobin (HbF) or other Hb variants retaining two native ? subunits. The phthalide compound is used to substitute for or cooperate with 2,3-BPG, to play a role of a 2,3-BPG substitute, to act on the hemoglobin-based blood substitute to effectively substitute the function of normal hemoglobin in releasing oxygen to tissue cells, in order to maintain the cellular oxygenation level within a normal range.

Abstract: A method for improving the oxygen-releasing ability of hemoglobin, hemoglobin variants, recombinant hemoglobin or hemoglobin-based blood substitutes to organs or peripheral tissues in human bodies is disclosed by administering a compound of phthalides to a subject in need thereof. The compound of phthalides is characterized by a phthalide functional group which is represented as Formula I, and forms at least one hydrogen bond with ?Arg141 of hemoglobin, hemoglobin variants, recombinant hemoglobin or hemoglobin-based blood substitutes, stabilizing the ?1/?2 interface of hemoglobin, further stabilizing the oxygenated hemoglobin, hemoglobin variants, recombinant hemoglobin or hemoglobin-based blood substitutes in the low oxygen affinity “T” state and facilitating the oxygen release to the organs or the peripheral tissues.

Abstract: An adjustable aerodynamic lens system for aerodynamic focusing of aerosols comprises a hollow tube having an inlet terminal, an outlet terminal and a focusing segment located between the inlet terminal and the outlet terminal. The focusing segment includes a plurality of section tubes assembled in a manner to selectively focus aerosols of a specific average size. Each of the section tubes has a focusing orifice, and the diameters of the two adjacent focusing orifices are different. In specific, the section tubes having their focusing orifices of appropriate diameters are chosen according to the average size of aerosol particles to be focused, and assembled in sequence, so as to make aerosol fluid passing through to form a beam of aerosol particles with good focusing quality.

Abstract: A method for improving the oxygen-releasing ability of hemoglobin, hemoglobin variants, recombinant hemoglobin and hemoglobin-based blood substitutes to organs and peripheral tissues in human bodies is disclosed by administering a compound of phthalides to a subject in need thereof to improve the oxygen-releasing ability of hemoglobin, hemoglobin variants, recombinant hemoglobin and hemoglobin-based blood substitutes to the organs and the peripheral tissues in human bodies. The compound of phthalides is characterized by a phthalide functional group, and forms at least one hydrogen bond with ?Arg141 of hemoglobin, hemoglobin variants, recombinant hemoglobin and hemoglobin-based blood substitutes, stabilizing the ?1/?2 interface of hemoglobin, further stabilizing the oxygenated hemoglobin, hemoglobin variants, recombinant hemoglobin and hemoglobin-based blood substitutes in the low oxygen affinity “T” state and facilitating the oxygen release to the organs and the peripheral tissues.

Abstract: A method for improving the oxygen-releasing ability of hemoglobin to organs and peripheral tissues in human bodies is disclosed by administering ferulic acid to a subject in need thereof to improve the oxygen-releasing ability of hemoglobin to the organs and the peripheral tissues in human bodies. Ferulic acid forms a hydrogen bond with ?Val1 of hemoglobin, stabilizing the ?1/?2 interface of hemoglobin, further stabilizing the oxygenated hemoglobin, hemoglobin variants, recombinant hemoglobin and hemoglobin-based blood substitutes in the low oxygen affinity “T” state and facilitating the oxygen release to the organs and the peripheral tissues.

Abstract: An improved structure of an LED light includes a light source module and a heat dissipation module. The light source module includes a plurality the compartments formed therein and each of the compartments receives therein a light reflector and a light emission element. The compartments are provided with a seat at an end thereof distant from the light emission elements. Each of the compartments is provided with a cover mounted thereon. The heat dissipation module has an outer wall forming a heat dissipation fin section. The heat dissipation module receives therein a drive module electrically connected to the light emission element. The heat dissipation module is coupled to the seat. With such an arrangement, the loss of light is minimized to achieve optimum utilization. The heat dissipation module is kept away from the light source module so that excellent effect of heat dissipation can be achieved.

Abstract: An electronic apparatus with a touch input system is provided. When a complete touch signal is detected, a sliding angle and a sliding track of the complete touch signal are calculated. A menu operation interface with arc-shaped arrangement is displayed in a touch display screen when the sliding angle of the complete touch signal exceeds a predetermined angle. And when an incomplete touch signal is detected, a sliding angle and a sliding track of the incomplete touching signal are calculated for displaying a part of the menu operation interface with arc-shaped arrangement in the touch display screen.

Abstract: An electronic apparatus with a touch input system is provided. When a complete touch signal is detected, a sliding angle and a sliding track of the complete touch signal are calculated. A menu operation interface with arc-shaped arrangement is displayed in a touch display screen when the sliding angle of the complete touch signal exceeds a predetermined angle. And when an incomplete touch signal is detected, a sliding angle and a sliding track of the incomplete touching signal are calculated for displaying a part of the menu operation interface with arc-shaped arrangement in the touch display screen.

Abstract: A method and a system for filtering and displaying information from different sources are provided for a terminal device. In the method, a filtering program resident in the terminal device is provided to set at least one information type and one relevant interested condition, and the terminal device is connected to different information sources. After the terminal device connects to at least one information source corresponding to the information type, a specific information is extracted from at least one information updated by the information source according to the relevant interested condition, and the specific information is displayed on a desktop of the terminal device so as to assist a user in obtaining the important information more effectively.

Abstract: A cylinder tube of a toy gun is disclosed. A cylinder head is mounted on the cylinder tube of the toy gun. A tube passage is formed to penetrate through the cylinder head. Several air induction passages are formed circularly around the tube passage. A control device is applied to the air induction passages for opening or closing the air induction passages according to the forward or backward movement of the piston. As a result, much more air can be sucked into the air storage chamber immediately after the backward movement of the piston. Accordingly, the air capacity of the cylinder tube can be increased so as to produce larger air pressure for pushing the bullet to the outside of the toy gun, thereby improving the shooting performance of the toy gun and providing the simulated recoil effect, which simulates the real shooting.

Abstract: A piston structure of a toy gun is disclosed. An air induction passage and at least an air inlet are formed on the piston. In addition, a control device is applied to the piston for correspondingly opening or closing the air inlet according to the movement of the piston. As a result, much more air can be sucked into an air storage chamber immediately after the backward movement of the piston. Therefore, the air capacity of the air storage chamber of the cylinder tube can be increased so as to produce larger air pressure for pushing the bullet to the outside of the toy gun, thereby simulating the recoil effect of the real shooting and improving the shooting performance of the toy gun.